chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Loss of hearing in the left ear; Sore throat; Ears clogged; SEVERE muscle spasms; All of my muscles in my arms, legs, and cheeks were trembling constantly; One hard, tiny, tiny mucous ball from each cough; Tremendous sweats; I slept for 1 day; Headache; SEVERE chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DEAFNESS UNILATERAL (Loss of hearing in the left ear) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Hypoglycemia.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DEAFNESS UNILATERAL (Loss of hearing in the left ear) (seriousness criterion medically significant), OROPHARYNGEAL PAIN (Sore throat), EAR DISCOMFORT (Ears clogged), MUSCLE SPASMS (SEVERE muscle spasms), TREMOR (All of my muscles in my arms, legs, and cheeks were trembling constantly), PRODUCTIVE COUGH (One hard, tiny, tiny mucous ball from each cough), HYPERHIDROSIS (Tremendous sweats), HYPERSOMNIA (I slept for 1 day), HEADACHE (Headache), CHILLS (SEVERE chills) and PYREXIA (Fever). At the time of the report, DEAFNESS UNILATERAL (Loss of hearing in the left ear), OROPHARYNGEAL PAIN (Sore throat), EAR DISCOMFORT (Ears clogged), MUSCLE SPASMS (SEVERE muscle spasms), TREMOR (All of my muscles in my arms, legs, and cheeks were trembling constantly), PRODUCTIVE COUGH (One hard, tiny, tiny mucous ball from each cough), HYPERHIDROSIS (Tremendous sweats), HYPERSOMNIA (I slept for 1 day), HEADACHE (Headache), CHILLS (SEVERE chills) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 103.3 (High) 103.3.         Very limited information regarding these events has been provided at this time.  Further information has been requested.   This case was linked to MOD-2021-072199 (Patient Link).; Sender's Comments: Very limited information regarding these events has been provided at this time.  Further information has been requested.
Didn?t start noticing any possible symptoms unless later that night after receiving the vaccine. Around 930 pm I started experiencing a lot of nausea and what seems to be a migraine. Migraine lasted all through the night along with muscle spasm/aches in my hips and legs. Migraine and muscle aches carried into the following morning of 06/09/21. I have taken ibuprofen to help deal with the migraine and muscle aches.
Shot site was swollen and red and very tender for 3 - 4 days.  I have sick and missed work for that same amount of time.  I have a terrible headache, chills, body aches and extreme nausea.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 1/26/2022 ALLERGIC RHINITIS R09.02 HYPOXIA 1/26/2022 ALLERGIC RHINITIS
SM notes he had large local reaction with his 3rd, 4th and 5th anthrax shots, including redness, swelling and pain at injection site. Erythema Start: 07/2003; Swelling Start: 07/2003; Pain Start: 07/2003; Pain Start: 09/2004; Erythema Start: 09/2004; Swelling Start: 09/2004; Erythema Start: 07/2006; Pain Start: 07/2006
This spontaneous report as received from registered nurse refers to a 26 year old female patient. On 10-JUN-1997 as a child, the patient was vaccinated with RECOMBIVAX HB injection 2.5/0.5 (dose unit, route, lot number and expiry date unknown) first dose. Patient received second and third dose on 10-JUL-1997 and 10-AUG-1997 respectively. Nurse reported that after receiving 3 doses of RECOMBIVAX HB injection, now at the age of 26 years, patient showed negative titers to hepatitis B. Nurse reported the patient was due to start medical school and the school has requirement of immunity to hepatitis B by 01-MAR-2014. Patient visited office. Nurse stated that the patient received RECOMBIVAX HB on 31-JAN-2014 and she was trying to administer an accelerated dosing of RECOMBIVAX HB to the patient. The outcome of is showing negative titers to hepatitis B after receiving unspecified hepatitis B as a child, received an unspecified hepatitis B as a child on 06/10/1997, 07/10/1997 and 08/10/1997 and patient received RECOMBIVAX HB on 01/31/2014 was unknown. No further information provided. Additional information has been requested.
Increased sleeping, eyes have red rings around them, low grade fevers, lethargic.
On 15Jan2009, pt was administered the Influenza vaccine, Flulaval, instead of Afluria (approved for the pregnant populaton).
This spontaneous report was received from a physician via a company representative refers to a 25-year-old female patient of unknown age with no pertinent medical history and drug reactions/allergies. On an unknown date in 2008 the patient who completed GARDASIL (20 micrograms(mcg) - 40 mcg-20mcg/0.5 ml 1 standard package vial of 0.5) (lot#, expiration date not reported) series, 0.5 milliliter (ml), intramuscularly. Concomitant medications included unspecified birth control pills. On an unknown date in 2013 (reported as recently) patient had Pap smear and HPV DNA test done. The Pap smear result came back normal but she tested positive for HPV 16 on an unknown date in September 2013. No additional information provided. Treatment was not rendered for the event. Additional laboratory investigations included Colposcopy (results pending). Patient sought medical attention by office visit. The event was not resolved at the time of this report. Causality was not reported. Additional information has been requested.
Radiating pain up and down my left leg, extreme difficulty walking or standing for 2 weeks (required prednisolone), pain when lifting leg, sciatic nerve problem. Numbness and tingling in my left leg and left arm. Extremely high blood pressure (well above my normal).  These issues are still ongoing except the pain has lessened.
Swollen glands (axilla) of arm where vaccine was received, 2 remote papules with central white head distant to site of vaccine (abd and left anterior chest).
night after getting covid pfizer vaccine booster from pharmacy 11/15/2021, patient got up to use restroom, had syncopal episode when walking to bed
Swoolen right arm and shoulder; Tenderness and hardness over right shoulder; Hardness over right shoulder; Swollen lymph nodes on right side; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, the patient experienced SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side). At the time of the report, SWELLING (Swoolen right arm and shoulder), TENDERNESS (Tenderness and hardness over right shoulder), INDURATION (Hardness over right shoulder) and LYMPHADENOPATHY (Swollen lymph nodes on right side) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       At the time of this report, symptoms were still ongoing. Patient was taking blood pressure pills as concomitant medications.   Treatment information was not provided.
8pm to 12am Chest pain and heart attack with no other cardiac history or risk factors.  Evaluated at hospital.  Abnormal EKG and troponin of 20. Cardiac catheterization revealed a spontaneous coronary artery dissection of the LAD. Cardiac ICU for observation and medical management. Echocardiogram revealed normal heart function despite the dissection.
Dec 17: Red Bumps, severe itching, arms, legs, shoulders, forearms, wrist, back. and hands. Headached, and tiredness. Jan 1st, Episode, fast heart beat, feeling faint, unbalanced, and dizziness.
rash on his chest and back of legs; This is a spontaneous report from a contactable pharmacist.  A 37-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number FA7485), via an unspecified route of administration on an unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. After 2 days of vaccination on an unspecified date the patient experienced later developed a rash on his chest and back of legs. He had taken Benadryl and using an anti-itch cream, today it's a lot better, but not completely better. Reporter queried for should he still get the second dose or will that prevent the second dose from happening. Reporter stated that "reporter doesn't had a primary care provider. Reporter was pretty familiar with vaccine considering he give it a lot. Reporter further stated that Of course, reporter brother would be the one who gets the one reaction that reporter haven't seen or heard of. Reporter stated that could rule out anaphylaxis because it was delayed, but if he were to go to urgent care, he would had probably give him steroids. Reporter queried for are they not contraindicated to use at the same time. The outcome of the events was unknown.
She has had outbreaks on her skin, then it appears on her back; It feels like a burning sensation It is spreading to part of her leg; it caused  her depression; Her leg is becoming sensitive; had a horrible rash under her breast, in between her chest, which spread all over her back, and her forehead; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISORDER (She has had outbreaks on her skin, then it appears on her back), BURNING SENSATION (It feels like a burning sensation It is spreading to part of her leg), DEPRESSION (it caused  her depression), SENSITIVE SKIN (Her leg is becoming sensitive) and RASH (had a horrible rash under her breast, in between her chest, which spread all over her back, and her forehead) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SKIN DISORDER (She has had outbreaks on her skin, then it appears on her back), BURNING SENSATION (It feels like a burning sensation It is spreading to part of her leg), DEPRESSION (it caused  her depression), SENSITIVE SKIN (Her leg is becoming sensitive) and RASH (had a horrible rash under her breast, in between her chest, which spread all over her back, and her forehead). At the time of the report, SKIN DISORDER (She has had outbreaks on her skin, then it appears on her back), BURNING SENSATION (It feels like a burning sensation It is spreading to part of her leg), DEPRESSION (it caused  her depression), SENSITIVE SKIN (Her leg is becoming sensitive) and RASH (had a horrible rash under her breast, in between her chest, which spread all over her back, and her forehead) outcome was unknown.            Patient went to a dermatologist and she was given some medications.  No treatment and concomitant medications were provided.  Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to MOD-2021-060501, MOD-2021-060501.
Swollen lymph nodes, migraines, hip pain and inflammation, lower back pain and inflammation.
This spontaneous report as received from a pharmacist to a 58 years old female patient with no pertinent medical history and drug allergies reported, who on 25-JAN-2013 was vaccinated with 0.65 ml ZOSTAVAX lot # (671610/1164AA) (route not provided). No other co-suspects were reported. No concomitant medications were reported. The Pharmacist stated that there was any adverse effects reported at this time. Additional information has been requested. 04-Feb-2013: This is an amended report. Potential Lot box checked as no in Product Details.
After about 10 minutes of getting vaccine, throat started to swell. Nurses at the site administered Epi pen. Taken to ER via ambulance. Give Benadryl and other medicine that I cannot remember. kept for observation about 4 hours and released.
Side effects; This case was reported by a pharmacist via call center representative and described the occurrence of adverse drug reaction in a elderly female patient who received Herpes zoster (Shingrix) (batch number 477S3, expiry date 17th October 2021) for prophylaxis.   On 6th October 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced adverse drug reaction. On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Shingrix.  Additional information was provided as follows: The patient experienced side effects after receiving 1st dose. Due to side effects, the patient did not received 2nd dose of vaccine. The reporter consented to follow up. The pharmacist did not have specific data related to the side effects statement and she advised the patient on the hesitancy due to exposure risk concerns. No additional details given to the agent.
Information has been received from a healthcare worker concerning a patient who was vaccinated with a dose of varicella virus live (Oka/Merck). The patient was given a prescription to receive zoster vaccine live (Oka/Merck) (MSD) and the pharmacy administered varicella virus vaccine live (Oka/Merck). It was unclear exactly how the error was made and if there was any product confusion. The error was discovered and the patient then received zoster vaccine live (Oka/Merck) (MSD). No problems were reported. Unspecified medical attention was sought. There was no product quality complaint involved. No further information is expected.
Visual changes - trouble focusing, double vision.  Vision gets better when she closes 1 eye.  Started when she was walking to car after flu shot (9/28) - and continued for 3 days.
1 hr post injection, sweaty and chills, nausea  4 hours post injection, dizziness, extreme fatigue, nausea, chills, feverish(99.8-100), flushed 12 hours post injection, extreme fatigue, nausea, headache, feverish (99.8)   Medicated for nausea and fever, otc meds Tylenol, perscribed meds Zofran
Resident nonverbal, therefore did not say anything to staff at any point. Resident started with a shaking/shivering 11/4/22 in the evening. VS WDL and other assessments showed no abnormalities. Shivering subsided later in the evening. Next day resident passed away (11/5/2022)
Presented for SOB, admit for COVID PNA. Tx w/abx, steroid, remdesivir, Toci, O2. No PMH. At time of DC on RA.
I was spotting prior to getting the vaccine. I am due to get it this week. Then after the vaccine I started that night bleeding a lot. I had to start to soak thru pads a lot. It continued through the weekend, I called my on-call doctor on Sunday and had a telehealth visit Monday with the doctor. They think it could be contributed to the vaccine. It has become better and back to normal by today 12/22/2021. The other symptoms I have is a headache after the booster and had it up until last night. I treated the headache with ibuprofen and Tylenol. The headache has resolved as of today.
pt recv vax & devel an inj site rxn characterized by redness extending from the shoulder to the elbow;pt also exp a sl fever & some joint aches;No further details known as of the reporting date
Congestion, redness in nostril. Next day wheezing and congestion swelling of nostrils and throat. Treatments of Benadryl and albuterol.
Subject reports that three days after receiving the ANTHRAX vaccine she felt chest pain and fainted for approximately 30 seconds. Subject was taken to ER by her friend (who has witnessed the event). Test preformed included EKG, blood work (specific tests unknown) chest x-ray and urine pregnancy tests which were all negative. She reports she was discharged from the ER to return home. No further episodes or additional complaints.
An initial report was received from a nurse on 16.Oct.2012 and concerns a 65-year-old male patient, who on 12.Oct.2012, received an oral administration of VIVOTIF (batch no.: 3000201). The patient's medical history and concomitant medications were not provided. On an unspecified date, following administration of the second dose of the vaccination, the patient experienced mild diarrhea. On an unspecified date, the event resolved by itself. The patient will continue with dose. The events were considered non-serious.
Patient received her first Pfizer Covid vaccine, sat down for the waiting period and fainted 1-2 minutes afterwards. She states she thinks she was only out for about a minute. Came to on her own. Pulse checked by personnel at the vaccine clinic. Patient then called her PCP's office (me) to report the event.
After vaccination, patient complaining of chest pain / pressure, and sense of impending doom.Medication administered per EMS EPI given x2 at 0956 and 1015 ASA 325 chewable given at 1004 for c/o crushing chest pain. Emergency response provider arrived present.  Pt started with c/o epigastric and then crushing CP.  Pt appeared to be unresponsive at 1020 but the several minutes later she is arousable and anxious, breathing labored and she is stating she is "going to die".  Transported to ED where delirium was noted and due to elevated ammonia level current presumptive diagnosis is hepatic encephalopathy.
Patient received FLUZONE & PNEUMOVAX and hours later reported red/itchy eyes, stiff arm, headache, chills. Treated for vaccine allergy.
Booster dose was given to an ineligble person. This individual was 13. The parents are aware. We kept him  for 30 minutes, and told them to contact their pediatrician.   13 year old is feeling well and parent is willling to speak with pediatrician and sign up for v-safe.
The Vaccine administered to the patient was administered outside of the 2  hour at room temperature window for the Janssen covid 19 vaccine (was at room temperature for about 5 hours). No issues reported by patient.
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. The patient's medical history or concurrent conditions were not reported. On 22-SEP-2016, the patient was vaccinated with an expired dose of PNEUMOVAX23 (which had the lot # L002310, expiration date July 2016) (dosage information was not informed) intramuscular route, for prophylaxis. Information regarding concomitant medication was not provided. It was also informed that no adverse effects were reported and there was no product quality complaint involved. Additional information has been requested.
Fever reaching 101 F for about 15 hours. Weakness. Headache.
Insomnia (36 hours, Fever (highest at 101.5), body aches (36 hours), headache (on and off )
Shortness of breath, nausea, pain in lower back, high blood pressure--lasted 10-15mins. and resolved by itself. Paramedics came, assessed him, took his blood pressure and said he could go home if he wanted. He declined need to go to hospital. He stated he felt back to normal and went home.
Sore arm; Extremely tired; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 16Apr2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2, anxiety, high blood pressure and high cholesterol. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications taken within two weeks of vaccination included insulin glargine (LANTUS) (reported as Lantus Solostar), glipizide (MANUFACTURER UNKNOWN), Centrum Silver and lysine (MANUFACTURER UNKNOWN) all taken for unknown indication from unknown date and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 26Mar2021 at 10:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Apr2021 at 12:00, the patient experienced sore arm and felt extremely tired. Therapeutic measures were taken as a result of the events and included treatment with acetaminophen (MANUFACTURER UNKNOWN) and sleep. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events sore arm and extremely tired was resolving at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
lost a lot of weight; No appetite; almost immediately my digestive system shut down; absolutely no bowel movements/no movement/no contractions/like gut was paralyzed/it was dead; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (almost immediately my digestive system shut down), CONSTIPATION (absolutely no bowel movements/no movement/no contractions/like gut was paralyzed/it was dead), WEIGHT DECREASED (lost a lot of weight) and DECREASED APPETITE (No appetite) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included ZOLPIDEM TARTRATE (AMBIEN) for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced ABDOMINAL DISCOMFORT (almost immediately my digestive system shut down) and CONSTIPATION (absolutely no bowel movements/no movement/no contractions/like gut was paralyzed/it was dead). On an unknown date, the patient experienced WEIGHT DECREASED (lost a lot of weight) and DECREASED APPETITE (No appetite). At the time of the report, ABDOMINAL DISCOMFORT (almost immediately my digestive system shut down) and CONSTIPATION (absolutely no bowel movements/no movement/no contractions/like gut was paralyzed/it was dead) had not resolved and WEIGHT DECREASED (lost a lot of weight) and DECREASED APPETITE (No appetite) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Patient took laxatives every 4 days.  Patient said that before receiving the 2nd dose, she had a bowel movement every morning. She is normally healthy individual with no underlying conditions. She drinks a lot of water and even does yoga. Her GI doctor said that she is doing everything right. She also says that she has not had any appetite and has lost a lot of weight due to this since receiving the 2nd dose She knows that she needs the nutrition so she forces herself to eat. She has a colonoscopy scheduled in DEC2021 for further examinations.